Published in Women's Health Weekly, August 17th, 2006
Study 1: PPAR-gamma activation by rosiglitazone resulted in decreased manifestation of inflammatory hallmarks more strongly in a pregnant diabetic animal model.
According to a study from Israel, "The peroxisome proliferator activating nuclear receptors (PPAR) are activated in the context of inflammation, diabetes or normal pregnancy. Renal mesangial cells express PPAR-gamma which upon activation are capable of exerting anti-inflammatory effects."
J. Weissgarten and colleagues at the Assaf Harofeh Medical Center explained, "We investigated the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.